Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
676 Views
eMediNexus 19 January 2018
A Cochrane meta-analysis noted that all major treatment classes reviewed were more effective than placebo for moderate to severe psoriasis; however, biologic agents appeared to be the most efficacious. Evaluation of data from 109 studies revealed that anti-IL17, anti-IL12/23, anti-IL23, and anti-TNF alpha drugs were superior for achieving PASI 90 status (90% reduction in Psoriasis Area and Severity Index score). All of the anti-IL17 drugs and guselkumab were found to be more effective than the anti-TNF alpha drugs infliximab, adalimumab, and etanercept for attaining PASI 90 status. Ustekinumab, an IL-12/23 inhibitor, was better than etanercept. Tofacitinib was superior to methotrexate. The findings are published online in Cochrane Library.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
Benefits of Resistance Training in Boosting Cardiometabolic Health in .....
Impact of Induction Timing on Maternal and Neonatal Outcomes..
COPD: A Potential Risk Factor for Herpes Zoster..
FDA Approves LEQSELVI for Severe Alopecia Areata..
Indolent Rhinovirus Infection in Preschoolers with Recurrent Wheeze: A.....
{{Article_Title}}..
Surge in Suspected Guillain-Barré Syndrome Cases in Pune Triggers Health Alert..
Needle Found in Newborn's Leg Sparks Negligence Allegations against Kannur Hospital..
IMA Warns against 'Mixopathy' While Supporting Alternative Medicine..
Probe Ordered after Govt. Medicines Dumped in J-K's Rajouri..
Anxiety and Relationship Issues Dominate Mental Health Concerns in Delhi: Report..